Exceptional response to everolimus in an NF1-deficient recurrent endometrioid adenocarcinoma: a case report - Quiz - MDSpire

Exceptional response to everolimus in an NF1-deficient recurrent endometrioid adenocarcinoma: a case report

  • By

  • Maja Machulak

  • Magdalena Zwierzchowska

  • Kinga Łysak

  • Kamil Kośmider

  • Katarzyna Szklener

  • Magdalena Skórzewska

  • May 25, 2026

  • 0 min

Share

Original Source(s)

Exceptional response to everolimus in an NF1-deficient recurrent endometrioid adenocarcinoma: a case report

  • by Maja Machulak, Magdalena Zwierzchowska, Kinga Łysak, Kamil Kośmider, Katarzyna Szklener, Magdalena Skórzewska

  • May 25, 2026

Related Content

MRI perfusion in evaluating ovarian masses: diagnostic performance of wash out rate

Recurrent IDH-mutant astrocytoma WHO grade 4 diagnosed during pregnancy: case report with literature review

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry